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Studies on  the  antigenicity of synthetic polymers of amino  acids  and  of 
hapten  conjugates  of  these  polymers  have  provided  important  information 
concerning the complex steps involved in the induction of antibody synthesis 
by protein antigens. Polyamino acids of a single a-amino acid such as poly-z- 
lysine or poly-l~-glutamic acid are not recognized as antigens (1, 2). In contrast, 
random copolymers containing comparable amounts of 3 or 4 L-amino acids, 
such as glutamic acid, lysine, and alanine (GLA),  1 or glutamic acid, alanine, 
and tyrosine (GAT), or GLAT, have been found to be antigenic in rabbits. 
(2,  3), guinea pigs (4),  and man (5),  in nearly every subject tested. Random 
copolymers of 2 L-amino acids GA, GL, or LA, induce also an immune response 
in guinea pigs (4, 6) but only in some animals and not in others. The ability 
to recognize these polyamino acids as antigens may depend on the ability of 
the  animals  to  recognize  specific  antigenic  determinants  and  also  on  their 
capacity to metabolize the molecule. Experiments with hapten conjugates of 
poly-L-lysine suggest that  the  failure of some of the  guinea pigs  to  be im- 
munized by certain copolymers of a-amino acids is not caused by the absence 
of antigenic determinants on these polymers but stems from the genetic in- 
capacity of some guinea pigs to process these substances in the precise way 
required to induce antibody synthesis. Thus only about 30 per cent of random- 
bred, Harfley strain guinea pigs produce antidinitrophenyl (DNP) antibodies, 
when  immunized with  DNP  conjugated with  polylysine  (7)  although  this 
hapten is recognized as an antigenic determinant by 100 per cent of guinea 
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pigs if conjugated to foreign or guinea pig proteins. It should also be stressed 
that guinea pigs capable of recognizing DNP-polylysine as an antigen are also 
able to produce antibodies against other immunologically unrelated haptens 
on polylysine such as benzyl penicilloyl or paratoluenesulfonyl (8),  and also 
against  the copolymer of L-glutamic acid and  •-lysine  (GwL,o)  (7).  Guinea 
pigs unable to produce antibodies to DNP-polylysine fall also to recognize GL 
or other hapten polylysine conjugates as antigens. Contrasting with the anti- 
genicity of GL and DNP polylysine, the ability of guinea pigs to recognize 
copolymers of  L-glutamic acid  and  L-alanine  (GcoA,0) and  DNP-polylysine 
does not appear to be related  (6). 
The observations with the polylysine hapten conjugates and the copolymers 
of GA and GL strongly suggest that besides the recognition of the antigenic 
determinant capable of inducing specific antibody synthesis, an earlier step of 
metabolism of the antigen molecule must take place, presumably at the level 
of the macrophages, for the inducer to be made (9, 10). Recent observations of 
Maurer  (11)  and  Gill et  o2.  (12)  that copolymers of D-amino acids, are not 
antigenic in  rabbits  and  guinea pigs  while the  corresponding conjugates of 
L-amino acids with the same relative composition behave as antigens in these 
species, are compatible with this interpretation. 
To confirm and extend these observations use was made of the fact that 
paraarsanilic acid (AS), a hapten which is universally recognized as antigenic 
by random-bred guinea pigs, can be conjugated by diazotization on the tyro- 
sines of both L-GAT or D-GAT. ASL-GAT  ~ was found to be antigenic in 100 
per cent of guinea pigs immlmized; the specificity of the antibodies produced 
was  directed  predominantly against  the  arsanilic  acid  determinant.  Under 
identical conditions of immunization and dosage, equal amounts of ASD-GAT  ~ 
failed to induce antibody synthesis in any of the guinea pigs tested, in spite of 
the fact that the antiarsanilic antibodies produced by guinea pigs immunized 
with ASL-GAT could be shown to react with ASD-GAT, thus verifying the 
effectiveness of the arsanilic acid determinant on the non-antigenic  arsanilic 
acid conjugate of the D-amino acid polymer. 
Methods 
Animals.--Male  and female  Hartley strain guinea  pigs, weighing  300 to 450 gm. were used 
Antigens.--Random  copolymers  of D- or L-glutamic  acid (G), tyrosine (T), and aL~nine 
(,%) were prepared by random polymerization  of the N-carboxy anhydrides of the a-amino 
adds. The methods  of preparation of the polymers  and the techniques  employed  in determin- 
ing the average molecular  weights  have been described (13). Two preparations have been used 
in these experiments: a cop01ymer of L-glutamic  acid, L-alanine,  and L-tyrosine  (L-GAT)  with 
a mole  per cent composition  60 per cent glutamic  acid, 30 per cent alanine, 10 per cent tyrosine, 
and an average molecular weight of 25,000, and a copolymer of D-glutamic acid, D-alanine, 
2 ASL-GAT, arsanilic  acid, L-glutamic  acid, L-alanine,  and L-tyrosine;  ASD-GAT, arsanilic 
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and D-tyrosine  (D-GAT) with the same relative mole per cent composition  as the L-amino 
acids and an average molecular weight of 33,000. 
Guinea pig serum albumin (GPA) was prepared by starch block electrophoresis of normal 
guinea pig serum. 
Arsanilic acid conjugates (AS) of these preparations were made by diazotization (14). The 
number of arsanill  c acid groups in the conjugates was estimated from the optical density of 
the preparations at 330 m/~ using as reference the absorption coefficient of chloracetyltyrosine 
azo arsanilic  acid at that wave length. The following conjugates were used: ASD-GAT  prepara- 
tion I;  16 groups/mole, preparation H;  7 groups/mole, preparation III; 13  groups/mole, 
ASL-GAT preparation I; 11 groups/mole, preparation II; 10 groups/mole, preparation III; 
5  groups/m01e,  preparation IV;  8  groups/mole, ASGPA preparation I;  31  groups/mole, 
preparation iI; 24 groups/mole. 
Immunization.--The antigens were dissolved in 0.15 ~ NaC1 and emulsified with an equal 
volume  of complete adjuvants  (Difco  Laboratories, Inc.,  Detroit). The immunizing dose 
contained in 0.4 ml was distributed into the four foot-pads. 
Skin Testing.--Intradermal  injections of 10 or 50/~g of the antigens in 0.1 ml of 0.15 M 
NaC1 were made at 1 week and again at 2 weeks after immunization. The reactions were 
observed at 2, 4, and 24 hours. The early reactions were graded +  to ++++  according to the 
severity of the edema and hemorrhage (15). The diameters of the induration or erythema of the 
delayed reactions were recorded. 3 to 7 days after the last skin test, the animals were bled and 
the sera tested for antibodies against the arsanilic acid hapten. 
Precipitin Test.--Capillary precipitin tests were carried out using undiluted sera and AS 
bovine fibrinogen at a concentration of 0.1 mg/ml, as described (16). 
Passive Cutaneous Anaphylaxls  (PCA).--PCA was carried out according to the technique 
of Ovary (17) using as antigen 0.5 mg of ASGPA 31 groups/mole, unless otherwise specified in 
Table HI. 
Systemic Anapkylaxis.--Some of the immunized  guinea pigs were injected intravenously 
with ASL-GAT, ASD-GAT, or ASGPA, and observed for symptoms of anaphylaxis. 
Passive Immune Lysis.--Tannic add-treated sheep red blood cells were prepared by the 
method of Stavitsky (18) and were coated with highly conjugated AS bovine fibrinogen. After 
washing, the: cells were resuspended  in phosphate-buffered  saline, pH 7.2. The titrations of 
antisera were performed after decomplementation at 57°C and absorption twice with sheep 
red blood cells. Starting with 1/10  dilutions, serial dilutions were made in 0.5 ml veronal 
buffer (19). To these were added 6 100 per cent units of guinea pig complement and 0.1 ml of 
the antigen coated cells. After incubation at 37°C for 30 minutes, the highest dilutions showing 
about 50 percent lysis were considered the lytic antibody titers. 
RESULTS 
The  immune  response  of guinea pigs immunized with  ASD-GAT or ASL- 
GAT are presented in Table I. None  of the 40  animals immunized with the 
arsanilic conjugates of the copolymer of D-amino acids showed any evidence of 
an immune response, either to the copolymer or to the arsanilic acid hapten. 
They were  uniformly negative to  skin tests with  10  or 50/~g  of ASD-GAT. 
They  showed  no  signs  of  anaphylaxis  when  challenged  intravenously  with 
ASD-GAT. The sera of 13 animals (Experiment 4), examined for antiarsanilic 
acid  antibodies by precipitin test  and  passive hemolysis,  were  all negative. 
Considering  the possibility that  copolymers of D-amino  acids might  behave 
like pneumococcal polysaccharides and be immunogenic only at very low dose TABLE I 
Immune Response of Guinea Pigs to Arsanilic Acid Conjugates of 
Copolymers of D-GA  T and I,-GA T 
Expeti-  No. of I  In~.uniz- 
ment  gmnea  mg 
pigs  antigen 
ASD.GAT 
1  10:[  16 group/ 
mole 
100/.tg 
2  7  7  group/ 
mole 
100/~g 
3  i0  7  group/ 
mole 
0.01/~g 
4  13§  13 group/ 
mole 
100 ~g 
ASL-GAT 
5  9  11 groupJ 
mole 
i00/~g 
6  9  10 group/ 
mole 
100/~g 
7'  9  10 group/ 
mole 
100/~g 
8  10  5 group/ 
mole 
100/zg 
9  8  8 group/ 
mole 
50pg 
10  14¶  8 group/ 
mole 
100/.~g 
14 days 24 hrs. skin 
reactivity*  Anti-AS-Ab  Anaphylaetic reactivity to: 
G~T  ASD-  ASL-  Ppt. PCA  ASD-  ASL-  GAT  G~T  GAT  GAT,  GAT,  ASGPA,  200/~g  200/~g  250  to  500/~g 
O/tO  0/10  O/lO 
o/7  o/7 
0/10  O/tO 
0/13  O/t311  0/13  0/13 
8/9  9/9  5/9  4/4 
4/9  9/9  3/9  6/6 
5/9  8/9  5 dead/$  4 dead/4 
10/10 
s/s  o/6  6/6 
8/14  14/14 
9 dead/lO 
1 severe 
shock 
12  dead/14 
2 severe 
shock 
* All skin tests: 10 ~tg of antigens. 
Eight of the animals were immunized 7 days later with 100 pg ASL-GAT, 11 g/M. All guinea pigs developed 
skin sensitivity and anaphylactic reactivity to this antigen at 2 weeks. 
§ The sera of these animals were tested for Tz complement-fixing  antiarsanilie antibodies by passive lysis of 
tanned SRBC  coated with AS bovine fibrinogen,  no lysis was observed at a dilution of 1/10. 
II These guinea pigs were also negative  when tested intradermally  with 50/Lg of ASD-GAT. 
¶ The sera of 13 of these animals were tested for q/2 complement-fixing antiarsanillc antibodies by passive lysls 
of tanned SRBC coated with AS bovine fibrlnogen, 5 of these sera contained lytic antibodies  in a titer of up to 
1/8o. 
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levels,  a  group  of 10  guinea  pigs  (Experiment 3)  was immunized with 0.01 
#g of ASD-GAT without evidence of an immune response. 8 of the animals from 
Experiment 1, which did not respond to immunization with ASD-GAT,  were 
immunized with 100/~g of ASL-GAT in complete adjuvants to verify that they 
TABLE II 
Skin Reactivity to ASD-GA T  of Guinea Pigs Sensitized to ASL-GA T 
Experi- 
ment 
No. 
I0 
Immunizing  antigen 
ASL-GAT, 
10 group/mole, 
100/~g 
ASL-GAT, 
8 group/mole, 
50/~g 
ASL-GAT, 
8 group/mole, 
100/~g 
Skin reactivity to 10/~g 
ASL-GAT, 8 or  ASD-GAT. 13 or 16 g/M 
2 hrs. 
4- 
++ 
+ 
++ 
+ 
++ 
=t= 
+ 
+ 
+ 
+ 
+ 
lo g/M 
24 hrs.  2 hrs. 
15  X  15  ± 
+q  15  X  15 
2O  X  20  - 
15  X  15  +q 
+  20  X  20 
40  X 40  +q 
8X8  4- 
Trace  + 
4- 
21  X  21 
11  X  11 
13  X  13 
14  X  14 
2O  X  20 
14  X  14  1 
14  X  14 
12  X  12 
20  ×  20 
30  X  30 
10  X  10 
20  X  20 
24 hrs.  24 hrs. 
50 ~g 
8×8 
10 X  10 
7X7 
10  X  10 
4- 
4- 
were capable  of an immune response  to ASL conjugates.  All developed ana- 
phylactic reactivity to ASL-GAT. 
Contrasting with the behavior of the animals immunized with ASD-GAT, 
all 59 guinea pigs immunized with the arsanilic acid conjugates of the copolymer 
of the L-amino acids produced antibodies against the axsanilic hapten, demon- 
strated either by anaphylactic reactivity of the animals to ASGPA, ASD-GAT, 
or ASL-GAT, or by examination of their sera by predpitin test or PCA. The 
sera of the guinea pigs from Experiment 10, were also assayed for 3'2 hemolytic 950  STUDIES  ON  ARTIFICIAL  ANTIGENS.  II 
(20) antiarsanilic acid antibodies which were found to be present in5 of the 13 
sera studied. 
It is interesting to note (Experiment 7) that the arsanilic acid conjugate of 
D-GAT could  provoke  lethal anaphylactic shock  in guinea pigs immunized 
with ASL-GAT in spite of the fact that it could not sensitize the animals. 
All but  1 of the 59  guinea  pigs immunized with ASL-GAT  showed, at 2 
weeks, skin reactions  to 10 #g of ASL-GAT.  The intensity of the immediate 
and delayed reactions  observed to ASL-GAT in Experiments 7, 9, and 10, are 
presented in Table II and are representative of all the animals studied. Delayed 
reactions to L-GAT were less frequent and less intense. No immediate reactions 
TABLE  III 
Passive Cutaneous  Anaphylaxis  Titers  of Sera from  Guinea  Pigs Immunized  with ASL-GAT 
against:  ASL-GA T, L-GA T, ASD-GA T, and ASGPA * 
Sera from  ASL-GAT  ASD-GAT  ASGPA  Experiment  guinea pig  8 g/M  L-GAT  7 g/M  31 g/M 
9 (see tables I and 
II) 
10 
1-0 
1-2 
1-4 
1-5 
2-2 
2-3 
1/looo, 
1/so 
1/so 
1/lo0 
1/1000 
1/IOO0 
1/5o 
Neg.§ 
Neg. 
Neg. 
1/lo0o 
1/so 
1/so 
1/loo 
1/looo 
1/looo 
1/500 
Trace 
1/5o 
1/so 
* Dose of challenging antigens 250/zg of L-GAT, ASL-GAT, ASD-GAT;  500/~g ASGPA. 
:~ Titers refer to highest dilution of sera giving positive PCA reactions  in an  average  of 
3 to 6 guinea pigs. 
§ Neg. refers to absence of reactions with lowest dilution used, 1/50. 
to L-GAT were observed.  A comparison  of the skin reactivity of guinea pigs 
immunized with ASL-GAT,  to  ASL-GAT and  ASD-GAT  is  also  found in 
Table II. Immediate hypersensitivity reactions  of comparable  intensity could 
be elicited by either 10/~g of ASD-GAT or ASL-GAT. Severe delayed reactions 
could only be provoked by the immunizing antigen and not by equal amounts 
of ASD-GAT; weak reactions were observed to 50 #g of ASD-GAT, illustrating 
the  extensive  immunological  specificity  of delayed reactions previously  de- 
scribed (15). Nevertheless, the ASD-GAT conjugates  could effectively combine 
with the antibodies  produced  against ASL-GAT as illustrated in Table III. 
The PCA titers of several  sera from guinea  pigs immunized with ASL-GAT 
towards GAT, ASL-GAT, ASD-GAT, and ASGPA, were examined. The GAT 
antibody titer was negligible, but ASD-GAT and ASL-GAT with comparable 
number of AS  groups  Were equally effective in eliciting  PCA  reactions  and 
behaved in this respect  a  little better  than ASGPA.  Similar  crossreactions, 
involving  glutamyl specificity,  between  D-GA, I)-GAT  and  poly-n-glutamic BARUJ  BENACERRAF,  ANTONIO  OJEDA,  AND  PAUL  H.  MALrRER  951 
acid and antibodies  produced to L-GA and L-GAT, was also observed by PCA 
(n). 
DISCUSSION 
The data presented show that an immunogenic hapten arsanilic acid, capable 
of inducing an antibody response,  specific for the hapten, when bound to a 
copolymer of 3L-a-amino acids, is not antigenic in guinea pigs when conjugated 
to  a  copolymer  of  the corresponding  D-amino acids  with the same relative 
composition and comparable molecular weight. These observations lend support 
to the concept  (21, 22, 11, 7), which postulates the metabolism of the antigen 
previous to the formation of the immunogeuic fragment carrying the antigenic 
determinant and capable of inducing antibody synthesis.  The nature of these 
metabolic steps have not been investigated, but it is reasonable  to assume in 
keeping  with the evidence of Fishman and Adler  (9,  10), that they involve 
first the cleavage of the antigen in the macrophages  by proteolytic enzymes. 
This process may be blocked in the case of polymers containing D-amino acids. 
Fishman and Adler reported also that small molecular weight RNA extracted 
from macrophages  incubated with antigen was capable  of inducing antibody 
production by rat lymph node cells (10). The problem arises whether this RNA 
is acting as an acceptor and transporter for the immunogenic fragment as is 
suggested by the observations  of Garvey and Campbell who were able to ex- 
tract  fragments of antigen bound  to  nucleic  acid from liver  of immunized 
animals (22). Such RNA acceptors  would be expected  to be specific for the 
terminal amino acids  of the immunogenic fragment. 
The  study of  the  immunogenic  fragments produced  by  macrophages  is 
essential to a better understanding of the early steps of induction of antibody 
synthesis. The use of well-defined synthetic polyamino acids antigens to which 
trace labeled antigenic haptens are conjugated, may prove to be highly suitable 
for such an investigation. 
SUMMARY 
An effort was made to immunize  guinea pigs with arsanilic acid conjugates 
of copolymers of D- and L-a-amino acids; ASD-GAT  and ASL-GAT. An im- 
mune response was observed only in the case of ASL-GAT. Antibodies specific 
for the arsanilic acid hapten were produced which could also react with ASD- 
GAT or ASGPA. These  findings indicate that the proper  metabolism of the 
antigen may be essential to the induction of the immune response. 
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